APUS

Conviction 63HealthcareScan · Mon, Aug 10, 2026

APUS$4.24+0.24%

ResistanceSupportVol 14

Vol MA14 76.27K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Apimeds Pharmaceuticals US, Inc.PHARMACEUTICAL PREPARATIONSwww.apimedsus.com ↗

Price4.24

Change+0.24%

Gap+0.24%

Rel volume0.04×

Avg volume100.11K

Avg $ vol269K

SMA 203.44

SMA 502.02

SMA 2001.69

Price vs 50+109.79%

Price vs 200+150.61%

MA stackbullish

50/200 crossgolden · 6d

Supertrenddown · 6.94

RSI (14)57

MACD hist-0.05

MACD crossbear · 0d

Stoch %K / %D47 / 50

ADX (14)45

+DI / −DI33 / 14

RSI divergence—

MACD divergenceBullish

ATR %+19.72%

ADR %19.83%

52w high8.00

52w low0.0000

From 52w high-47.00%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width278.12%

%B0.58

Donchian pos47.32%

Donchian high8.28

Donchian low0.6149

AVWAP (52w high)5.80

vs AVWAP high-26.95%

AVWAP (52w low)2.47

vs AVWAP low+71.53%

OBV trendDown

Chaikin MF (20)-0.54

Today vs 20d0.04×

Avg vol (14d)76.27K

Avg vol (20d)100.11K

Avg $ vol (20d)269K

Market cap—

RS 3m (vs SPY)+186.03%

RS 6m (vs SPY)+175.61%

RS line new highNo

Trend template4/8

Technical rank91.7

1 week-12.58%

1 month+488.89%

3 months+180.15%

6 months+161.73%

1 year+170.06%

YTD+154.65%

P/E-11.45

P/B0.54

P/S—

P/FCF-7.65

EPS-0.5500

Div yield—

ROE-4.74%

ROA-4.25%

Debt/Eq0.00

Current0.90

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-331.74%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value67.78M

Revenue—

Net income-35.06M

Gross profit—

Free cash flow-8.98M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out15.09M

Employees7

ListedFri, May 9, 2025

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction63 / 100

Pattern quality—

Tech rank91.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.91

Support0.6472

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in APUS

All disclosures →

No recent disclosed trades by Congress in APUS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in APUS

No recent insider (Form 4) filings in APUS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in APUS · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.